首页 | 本学科首页   官方微博 | 高级检索  
     

湖北省医疗机构制剂室现状和情况讨论
引用本文:陈相龙,张国强,刘文斌,阮祥庆,张学义,赵瑛. 湖北省医疗机构制剂室现状和情况讨论[J]. 中国医院药学杂志, 2017, 37(14): 1327-1329. DOI: 10.13286/j.cnki.chinhosppharmacyj.2017.14.01
作者姓名:陈相龙  张国强  刘文斌  阮祥庆  张学义  赵瑛
作者单位:1. 湖北省食品药品监督管理局, 湖北 武汉 430071;2. 华中科技大学同济医学院附属协和医院, 湖北 武汉 430030
基金项目:湖北省重点实验室开放基金研究项目(编号:0203201406)
摘    要:目的:为医疗机构制剂室的发展提供建议和对策。方法:汇总湖北省医疗机构制剂室的基本情况,分析其发展趋势并提出相关建议。结果:湖北省共有79家医疗机构制剂室,其所在地域、医疗机构级别和类别分布不均衡;西药制剂的同质化高,而中药制剂中独家特色制剂较多;近3年新批准医疗机构制剂数量不多;制剂室设施设备、质量检验和物料生产等方面普遍存在问题。结论:湖北省医疗机构制剂室发展存在一定的问题,建议引导制剂室合理布局,走向集中化、特色化,鼓励与药品生产企业联合注册申报制剂文号,实现医疗机构制剂室的可持续发展。

关 键 词:医疗机构制剂室  医疗机构制剂  发展  监管  
收稿时间:2016-10-08

Discussion on current status and development strategies of manufacturing laboratory in medical institutions of Hubei province
CHEN Xiang-long,ZHANG Guo-qiang,LIU Wen-bin,RUAN Xiang-qing,ZHANG Xue-yi,ZHAO Ying. Discussion on current status and development strategies of manufacturing laboratory in medical institutions of Hubei province[J]. Chinese Journal of Hospital Pharmacy, 2017, 37(14): 1327-1329. DOI: 10.13286/j.cnki.chinhosppharmacyj.2017.14.01
Authors:CHEN Xiang-long  ZHANG Guo-qiang  LIU Wen-bin  RUAN Xiang-qing  ZHANG Xue-yi  ZHAO Ying
Affiliation:1. Hubei Food and Drug Administration, Hubei Wuhan 430071, China;2. Department of Pharmacy, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Hubei Wuhan 430022, China
Abstract:OBJECTIVE To provide a reference for promoting the development of manufacturing laboratory in medical institutions.METHODS Through basic situation analysis of manufacturing laboratory in Hubei province, development trends were analyzed and suggestions were proposed.RESULTS There were 79 manufacturing laboratories in Hubei providence, with varied locations, levels, and categories. Chemical pharmaceutics showed high level of homogenization, but traditional medicines were unique depending on different medical institutions. A few pharmaceutics were approved to produce in last three years. There were general defeats existing in instruments, quality of drugs and raw materials.CONCLUSION There are some problems in the development of manufacturing laboratory in medical institutions in Hubei province. It is suggested to give rational distribution in all medical institutions, guide centralization of homogenization, specification of traditional medicine. It is also suggested that manufacturing laboratories should unite pharmaceutical enterprises to register preparations, to put manufacturing laboratories onto the sustainable track.
Keywords:manufacturing laboratory in medical institution  pharmaceutical preparations in medical institution  development  regulation  
点击此处可从《中国医院药学杂志》浏览原始摘要信息
点击此处可从《中国医院药学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号